Matrix synthesis and degradation in human intervertebral disc degeneration

Biochemical Society Transactions - Tập 35 Số 4 - Trang 652-655 - 2007
Christine L. Le Maitre1, Aneta J Pockert1, David J. Buttle2, A J Freemont1, Judith A. Hoyland1
1Tissue Injury and Repair Group, School of Medicine, Stopford Building, The University of Manchester, Oxford Road, Manchester M13 9PT, U.K.
2Academic Unit of Molecular Medicine, School of Medicine and Biomedical Sciences, E-Floor, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, U.K.

Tóm tắt

Degeneration of the intervertebral disc has been implicated in chronic low back pain. Type II collagen and proteoglycan (predominantly aggrecan) content is crucial to proper disc function, particularly in the nucleus pulposus. In degeneration, synthesis of matrix molecules changes, leading to an increase in the synthesis of collagens type I and III and a decreased production of aggrecan. Linked to this is an increased expression of matrix-degrading molecules including MMPs (matrix metalloproteinases) and the aggrecanases, ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) 1, 4, 5, 9 and 15, all of which are produced by native disc cells. Importantly, we have found that there is a net increase in these molecules, over their natural inhibitors [TIMP-1 (tissue inhibitor of metalloproteinases-1), 2 and 3], suggesting a deregulation of the normal homoeostatic mechanism. Growth factors and cytokines [particularly TNFα (tumour necrosis factor α) and IL-1 (interleukin 1)] have been implicated in the regulation of this catabolic process. Our work has shown that in degenerate discs there is an increase in IL-1, but no corresponding increase in the inhibitor IL-1 receptor antagonist. Furthermore, treatment of human disc cells with IL-1 leads to a decrease in matrix gene expression and increased MMP and ADAMTS expression. Inhibition of IL-1 would therefore be an important therapeutic target for preventing/reversing disc degeneration.

Từ khóa


Tài liệu tham khảo

Eyre, 1977, Biochim. Biophys. Acta, 492, 29, 10.1016/0005-2795(77)90211-2

Schollmeier, 2000, Spine, 25, 2736, 10.1097/00007632-200011010-00004

Taylor, 1992, J. Anat., 180, 137

Jahnke, 1988, Biochem. J., 251, 347, 10.1042/bj2510347

Roberts, 1995, Lumbar Spine Disorders: Current Concepts, 73, 10.1142/9789812831156_0008

Melrose, 2001, J. Anat., 198, 3, 10.1046/j.1469-7580.2001.19810003.x

Johnstone, 1995, Spine, 20, 674, 10.1097/00007632-199503150-00008

Inkinen, 1998, J. Rheumatol., 25, 506

Sztrolovics, 1999, Spine, 24, 1765, 10.1097/00007632-199909010-00003

Ohshima, 1995, J. Orthop. Res., 13, 22, 10.1002/jor.1100130106

Ohshima, 1993, J. Orthop. Res., 11, 332, 10.1002/jor.1100110304

Dolan, 2001, Clin. Biomech., 16, S8, 10.1016/S0268-0033(00)00096-6

Sive, 2002, Mol. Pathol., 55, 91, 10.1136/mp.55.2.91

Freemont, 1997, Lancet, 350, 178, 10.1016/S0140-6736(97)02135-1

Deyo, 2001, N. Engl. J. Med., 344, 363, 10.1056/NEJM200102013440508

Maniadakis, 2000, Pain, 84, 95, 10.1016/S0304-3959(99)00187-6

Freemont, 2002, J. Pathol., 196, 374, 10.1002/path.1050

Takaishi, 1997, J. Orthop. Res., 15, 528, 10.1002/jor.1100150408

Boos, 1997, Histochem. Cell Biol., 108, 471, 10.1007/s004180050187

Duance, 1998, Spine, 23, 2545, 10.1097/00007632-199812010-00009

Cs-Szabo, 2002, Spine, 27, 2212, 10.1097/00007632-200210150-00006

Pearce, 1987, J. Orthop. Res., 5, 198, 10.1002/jor.1100050206

Oegema, 2000, Spine, 25, 2742, 10.1097/00007632-200011010-00005

Cawston, 1996, J. Pathol., 180, 115, 10.1002/(SICI)1096-9896(199610)180:2<115::AID-PATH674>3.0.CO;2-I

Le Maitre, 2004, J. Pathol., 204, 47, 10.1002/path.1608

Le Maitre, 2006, Biotech. Histochem., 81, 125, 10.1080/10520290601005298

Roberts, 2000, Spine, 25, 3005, 10.1097/00007632-200012010-00007

Weiler, 2002, Eur. Spine J., 11, 308, 10.1007/s00586-002-0472-0

Goupille, 1998, Spine, 23, 1612, 10.1097/00007632-199807150-00021

Cawston, 1999, Ann. N.Y. Acad. Sci., 878, 120, 10.1111/j.1749-6632.1999.tb07678.x

Cawston, 1986, Proteinase Inhibitors, 586

Fosang, 1996, J. Clin. Invest., 98, 2292, 10.1172/JCI119040

Buttner, 1998, Biochem. J., 333, 159, 10.1042/bj3330159

Jones, 2005, Arthritis Res. Ther., 7, 160, 10.1186/ar1783

Nagase, 2003, Arthritis Res. Ther., 5, 94, 10.1186/ar630

Caterson, 2000, Matrix Biol., 19, 333, 10.1016/S0945-053X(00)00078-0

Pockert, 2006, J. Pathol., 210, 24

Gruber, 1998, Spine, 23, 751, 10.1097/00007632-199804010-00001

Maroudas, 1975, J. Anat., 120, 113

Le Maitre, 2005, Arthritis Res. Ther., 7, R732, 10.1186/ar1732

Ijima, 2001, Eur. J. Oral Sci., 109, 50, 10.1034/j.1600-0722.2001.00939.x

Maeda, 2000, Spine, 25, 166, 10.1097/00007632-200001150-00005

Rannou, 2000, Spine, 25, 17, 10.1097/00007632-200001010-00005

Shinmei, 1998, Spine, 13, 1284, 10.1097/00007632-198811000-00014

Doita, 1996, Spine, 21, 235, 10.1097/00007632-199601150-00015

Takahashi, 1996, Spine, 21, 218, 10.1097/00007632-199601150-00011

Takegami, 2002, Spine, 27, 1318, 10.1097/00007632-200206150-00014

Shen, 2003, Eur. Spine J., 12, 66, 10.1007/s00586-002-0454-2

Le Maitre, 2006, J. Pathol., 210, 56

Le Maitre, 2006, Int. J. Exp. Pathol., 87, 17, 10.1111/j.0959-9673.2006.00449.x

Le Maitre, 2006, J. Pathol., 210, 2

Le Maitre, 2005, J. Pathol., 207, 445, 10.1002/path.1862

Richardson, 2006, Biomaterials, 27, 4069, 10.1016/j.biomaterials.2006.03.017

Richardson, 2006, Stem Cells, 24, 707, 10.1634/stemcells.2005-0205

Thông tin
Thông tin xuất bản

Biochemical Society Transactions

Tập 35 Số 4

652-655

Thông tin tác giả